Characteristics and Functionality Enhancement by Glycosylation of Bitter Melon (Momordica charantia) Seed Protein

被引:16
作者
Horax, Ronny [1 ]
Hettiarachchy, Navam [1 ]
Chen, Pengyin [2 ]
机构
[1] Univ Arkansas, Dept Food Sci, Fayetteville, AR 72704 USA
[2] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA
关键词
bitter melon; functionality; glycosylation; protein; seed; CARP MYOFIBRILLAR PROTEIN; BETA-LACTOGLOBULIN; MAILLARD REACTION; EMULSIFYING PROPERTIES; WHEY-PROTEIN; IMPROVED SOLUBILITY; FOAMING PROPERTIES; GLYCATION; IMPROVEMENT; GLUCOSE;
D O I
10.1111/1750-3841.12680
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Seeds of ripe bitter melon (Momordica charantia) contain approximately 30% protein. However, this protein, which is less functional than soy protein, may have desirable functionalities as a food ingredient after modification. Bitter melon seed protein isolate (BMSPI) was prepared under optimal extraction conditions (defatted meal to 1.3 M NaCl was 1:10 w/v; pH 9.0) and its functional properties were investigated before and after modification by glycosylation. Glycosylation was conducted at varying relative humidities (50%/65%/80%) and temperatures (40 degrees C/50 degrees C/60 degrees C) using a response surface central composite design. Degree of glycosylation (DG) ranged from 39.3 to 52.5%, 61.7 to 70.9%, and 81.2 to 94.8% at 40 degrees C, 50 degrees C, and 60 degrees C, respectively (P values < 0.0001). Denaturation temperatures of all DGs ranged from 111.6 degrees C to 114.6 degrees C, while unmodified/native BMSPI had a value of 113.2 degrees C. Surface hydrophobicity decreased to approximately 60% when the DG was maximal (94.8%). Solubility decreased almost 90% when the DG was maximal in comparison to the native BMSPI (62.0%). Emulsifying activity increased from 0.35 to 0.80 when the DGs were 80%, while emulsion stability increased from 63 to 72 min when the DGs were greater than 70%. A similar trend was observed with foaming capacity and foaming stability of the glycosylated proteins. This glycosylated BMSPI with improved emulsifying and foaming properties could be used as an ingredient in food products where such properties are required.
引用
收藏
页码:C2215 / C2221
页数:7
相关论文
共 50 条
[21]   Bitter Melon (Momordica charantia L.) Supplementation Has No Effect on Hypercholesterolemia and Atherosclerosis in Mice [J].
Mohammadmoradi, Shayan ;
Howatt, Deborah A. ;
Lu, Hong S. ;
Daugherty, Alan ;
Saha, Sibu P. .
CURRENT DEVELOPMENTS IN NUTRITION, 2020, 4 (10)
[22]   Enhanced recovery of phenolic compounds from bitter melon (Momordica charantia) by subcritical water extraction [J].
Budrat, Parichat ;
Shotipruk, Artiwan .
SEPARATION AND PURIFICATION TECHNOLOGY, 2009, 66 (01) :125-129
[23]   Nutraceutical Potential of Bitter Melon (Momordica charantia) on Cancer Treatment: An Overview of In Vitro and Animal Studies [J].
Deligiannidou, Georgia-Eirini ;
Pritsa, Agathi ;
Nikolaou, Anastasios ;
Poulios, Efthymios ;
Kontogiorgis, Christos ;
Papadopoulou, Sousana K. ;
Giaginis, Constantinos .
CURRENT ISSUES IN MOLECULAR BIOLOGY, 2025, 47 (06)
[24]   Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes [J].
Pratibha V Nerurkar ;
Yun-Kung Lee ;
Vivek R Nerurkar .
BMC Complementary and Alternative Medicine, 10
[25]   Protective Effects of Momordica charantia (Bitter Melon) against Methotrexate-induced Kidney Damage [J].
Macit, Caglar ;
Ozbeyli, Dilek ;
Cevik, Ozge ;
Cetin, Melisa ;
Sener, Goksel ;
Ozkan, Sevil .
CURRENT DRUG THERAPY, 2023, 18 (03) :231-236
[26]   Cytotoxicity Analysis of Active Components in Bitter Melon (Momordica charantia) Seed Extracts Using Human Embryonic Kidney and Colon Tumor Cells [J].
Chipps, Elizabeth S. ;
Jayini, Renuka ;
Ando, Shoko ;
Protzman, April D. ;
Muhi, M. Zubayed ;
Mottaleb, M. Abdul ;
Malkawi, Ahmed ;
Islam, M. Rafiq .
NATURAL PRODUCT COMMUNICATIONS, 2012, 7 (09) :1203-1208
[27]   First Report of Zucchini Yellow Mosaic Virus Infecting Bitter Melon (Momordica charantia) in South Korea [J].
Lee, Hyo-Jeong ;
Cho, In-Sook ;
Jeong, Rae-Dong .
PLANT DISEASE, 2022, 106 (11)
[28]   Suppression of inflammatory cytokines expression with bitter melon (Momordica charantia) in TNBS-instigated ulcerative colitis [J].
Semiz, Asli ;
Acar, Ozden Ozgun ;
Cetin, Hulya ;
Semiz, Gurkan ;
Sen, Alaattin .
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2020, 8 (03) :177-187
[29]   Comparison of antioxidant capacities and antioxidant components of commercial bitter melon (Momordica charantia L.) products [J].
Akyuz, Esin ;
Turkoglu, Sercan ;
Sozgen Baskan, Kevser ;
Tutem, Esma ;
Apak, Mustafa Resat .
TURKISH JOURNAL OF CHEMISTRY, 2020, 44 (06) :1663-1673
[30]   Activating Effect of Momordin, Extract of Bitter Melon (Momordica Charantia L.), on the Promoter of Human PPARδ [J].
Sasa, Masatoshi ;
Inoue, Ikuo ;
Shinoda, Yuichi ;
Takahashi, Seiichiro ;
Seo, Makoto ;
Komoda, Tsugikazu ;
Awata, Takuya ;
Katayama, Shigehiro .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (06) :888-892